NEW ALBANY — Baptist Health Floyd recently completed its 500th Watchman procedure. The Watchman device is an alternative to ...
Add Yahoo as a preferred source to see more of our stories on Google. Fred Hughes of Cicero says the WATCHMAN procedure changed his life, after battling decades of serious heart issues. Valerie ...
A new Watchman device at McLaren Port Huron offers eligible AFib patients an alternative to long‑term blood thinners to help ...
Boston Scientific Corporation (NYSE:BSX) is one of the 8 Most Oversold Strong Buy-Rated Stocks to Invest In. On March 30, ...
Physicians wrestled with endpoint composition, low event rates, a possible difference in ischemic strokes, and more.
In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thin | Boston ...
MedPage Today on MSN
Watchman LAA Occluder Bounces Back as Alternative to OAC in CHAMPION-AF
Study suggests a path forward for device therapy, though caveats are plenty ...
Add Yahoo as a preferred source to see more of our stories on Google. SYRACUSE, N.Y. (WSYR-TV) — A Central New York man is sharing his story after decades of heart issues, and how a small device is ...
Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and ...
Boston Scientific (NYSE:BSX) announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Boston Scientific (BSX) stock tumbled 9% to two-year lows after Watchman trial data revealed stroke concerns and Raymond ...
CHAMPION-AF shows Boston Scientific's Watchman FLX as a safe, effective first-line option for stroke risk reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results